Summary

The global ophthalmic devices market is set to experience notable growth, driven by the rising prevalence of eye disorders and vision loss. These devices play a crucial role in diagnosing and treating ocular defects, deficiencies, and various eye conditions. With a moderate compound annual growth rate (CAGR) projected over the forecast period, the market is anticipated to expand significantly.

Key Market Dynamics

The increase in lifestyle-related ophthalmic disorders has become evident in recent years. Additionally, the aging population is facing more age-related eye conditions such as cataracts, glaucoma, and macular degeneration, which is driving the demand for ophthalmic devices. Conditions like diabetic retinopathy, visual impairment, blindness, bulging eyes, diabetic macular edema, ocular hypertension, retinal detachment, uveitis, and refractive errors are expected to further boost the market. The rising incidence of eye disorders among children is also projected to contribute to market growth during the forecast period.

Governments in developed regions are supporting advanced healthcare infrastructures and dedicated ophthalmic centers. In developing markets, there is a growing focus on promoting state-of-the-art healthcare infrastructure, which is expected to support market growth. Technological advancements in ophthalmic devices are leading to innovative and advanced healthcare solutions, generating substantial demand over the forecast period.

However, the market faces challenges such as inadequate awareness about eye disorders and treatment options in developing regions. Poor healthcare infrastructure and low prioritization of ophthalmic care are anticipated to hinder market growth. The lack of sufficient healthcare insurance and rising primary healthcare costs in these regions also pose significant challenges.

Segment Analysis

The global ophthalmic devices market is segmented by type into vision care devices, diagnostic devices, and surgery devices. The vision care devices segment is the largest, while the surgery devices segment is the fastest growing. Vision care devices are divided into contact lenses and spectacle lenses, with spectacle lenses being more commonly used. However, contact lenses are expected to see significant growth through the forecast period. The surgery devices segment includes cataract surgery devices, glaucoma surgery devices, refractive error surgery devices, and vitreoretinal surgery devices, with cataract surgery devices being the largest sub-segment.

The diagnostic devices segment encompasses optical coherence tomography (OCT) scanners, fundus cameras, slit lamps, tonometers, ophthalmoscopes, retinoscope, pachymeter, wavefront aberrometers, corneal topographers, biometers, keratometers, visual field analyzers (perimeters), specular microscopes, autorefractors, and ophthalmic ultrasound imaging systems.

Geographic Analysis

Geographically, the market is segmented into four key regions: North America, Europe, Asia, and the rest of the world. North America, particularly the U.S., is the leading market and is expected to maintain its dominance throughout the forecast period. Europe is also a significant market due to the rising incidence of chronic eye diseases among the elderly population. Asia, led by China and India, is anticipated to witness substantial growth due to a larger patient pool and high prevalence of cataracts, glaucoma, and diabetic retinopathy. The region is also experiencing an increase in age-related macular degeneration.

Key Market Players

The global ophthalmic devices market is highly competitive, with leading players continually focusing on developing and launching new products. Some of the prominent companies in the market include:

•Johnson & Johnson

•Bausch & Lomb Incorporated

•Novartis AG

•Abbott Laboratories, Inc.

•Essilor International

•Hoya Corporation

•VisionCare, Inc.

•Carl Zeiss AG

•Canon Inc.

•Nidek Co Ltd.

•Topcon Corp.

•Alcon Inc.

•CooperVision AG

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Ophthalmic Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Price Analysis, 2023
3.1. Global Average Price Analysis, by Product, US$ Per Unit, 2023
3.2. Prominent Factor Affecting Ophthalmic Devices Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit, 2023
4. Global Ophthalmic Devices Market Outlook, 2018 – 2031
4.1. Global Ophthalmic Devices Market Outlook, By Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
4.1.1. Key Highlights
4.1.1.1. Diagnostic Devices
4.1.1.1.1. Optical Coherence Tomography (OCT) Scanners
4.1.1.1.2. SLIT Lamps
4.1.1.1.3. Ophthalmoscopes
4.1.1.1.4. Keratometers
4.1.1.1.5. Autorefractors
4.1.1.1.6. Ophthalmic Ultrasound Imaging Systems
4.1.1.1.7. Pachymeter
4.1.1.1.8. Others
4.1.1.2. Surgical Devices
4.1.1.2.1. Cataract Surgical Devices
4.1.1.2.2. Refractive Error Surgical Devices
4.1.1.2.3. Glaucoma Surgical Devices
4.1.1.2.4. Vitreoretinal Surgical Devices
4.1.1.3. Vision Care Devices
4.1.1.3.1. Spectacle Lenses
4.1.1.3.2. Contact lenses
4.2. Global Ophthalmic Devices Market Outlook, By End User, Value (US$ Bn), 2018 – 2031
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Ambulatory Surgical Centers
4.2.1.3. Ophthalmic Clinics
4.2.1.4. Others
4.3. Global Ophthalmic Devices Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 – 2031
4.3.1. Key Highlights
4.3.1.1. North America
4.3.1.2. Europe
4.3.1.3. Asia Pacific
4.3.1.4. Latin America
4.3.1.5. Middle East & Africa
5. North America Ophthalmic Devices Market Outlook, 2018 – 2031
5.1. North America Ophthalmic Devices Market Outlook, By Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
5.1.1. Key Highlights
5.1.1.1. Diagnostic Devices
5.1.1.1.1. Optical Coherence Tomography (OCT) Scanners
5.1.1.1.2. SLIT Lamps
5.1.1.1.3. Ophthalmoscopes
5.1.1.1.4. Keratometers
5.1.1.1.5. Autorefractors
5.1.1.1.6. Ophthalmic Ultrasound Imaging Systems
5.1.1.1.7. Pachymeter
5.1.1.1.8. Others
5.1.1.2. Surgical Devices
5.1.1.2.1. Cataract Surgical Devices
5.1.1.2.2. Refractive Error Surgical Devices
5.1.1.2.3. Glaucoma Surgical Devices
5.1.1.2.4. Vitreoretinal Surgical Devices
5.1.1.3. Vision Care Devices
5.1.1.3.1. Spectacle Lenses
5.1.1.3.2. Contact lenses
5.2. North America Ophthalmic Devices Market Outlook, By End User, Value (US$ Bn), 2018 – 2031
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Ambulatory Surgical Centers
5.2.1.3. Ophthalmic Clinics
5.2.1.4. Others
5.3. North America Ophthalmic Devices Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. U.S. Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
5.3.1.2. U.S. Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
5.3.1.3. Canada Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
5.3.1.4. Canada Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Europe Ophthalmic Devices Market Outlook, 2018 – 2031
6.1. Europe Ophthalmic Devices Market Outlook, By Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
6.1.1. Key Highlights
6.1.1.1. Diagnostic Devices
6.1.1.1.1. Optical Coherence Tomography (OCT) Scanners
6.1.1.1.2. SLIT Lamps
6.1.1.1.3. Ophthalmoscopes
6.1.1.1.4. Keratometers
6.1.1.1.5. Autorefractors
6.1.1.1.6. Ophthalmic Ultrasound Imaging Systems
6.1.1.1.7. Pachymeter
6.1.1.1.8. Others
6.1.1.2. Surgical Devices
6.1.1.2.1. Cataract Surgical Devices
6.1.1.2.2. Refractive Error Surgical Devices
6.1.1.2.3. Glaucoma Surgical Devices
6.1.1.2.4. Vitreoretinal Surgical Devices
6.1.1.3. Vision Care Devices
6.1.1.3.1. Spectacle Lenses
6.1.1.3.2. Contact lenses
6.2. Europe Ophthalmic Devices Market Outlook, By End User, Value (US$ Bn), 2018 – 2031
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Ambulatory Surgical Centers
6.2.1.3. Ophthalmic Clinics
6.2.1.4. Others
6.3. Europe Ophthalmic Devices Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
6.3.1. Key Highlights
6.3.1.1. Germany Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
6.3.1.2. Germany Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
6.3.1.3. U.K. Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
6.3.1.4. U.K. Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
6.3.1.5. France Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
6.3.1.6. France Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
6.3.1.7. Italy Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
6.3.1.8. Italy Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
6.3.1.9. Türkiye Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
6.3.1.10. Türkiye Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
6.3.1.11. Russia Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
6.3.1.12. Russia Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
6.3.1.13. Rest of Europe Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
6.3.1.14. Rest of Europe Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Asia Pacific Ophthalmic Devices Market Outlook, 2018 – 2031
7.1. Asia Pacific Ophthalmic Devices Market Outlook, By Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
7.1.1. Key Highlights
7.1.1.1. Diagnostic Devices
7.1.1.1.1. Optical Coherence Tomography (OCT) Scanners
7.1.1.1.2. SLIT Lamps
7.1.1.1.3. Ophthalmoscopes
7.1.1.1.4. Keratometers
7.1.1.1.5. Autorefractors
7.1.1.1.6. Ophthalmic Ultrasound Imaging Systems
7.1.1.1.7. Pachymeter
7.1.1.1.8. Others
7.1.1.2. Surgical Devices
7.1.1.2.1. Cataract Surgical Devices
7.1.1.2.2. Refractive Error Surgical Devices
7.1.1.2.3. Glaucoma Surgical Devices
7.1.1.2.4. Vitreoretinal Surgical Devices
7.1.1.3. Vision Care Devices
7.1.1.3.1. Spectacle Lenses
7.1.1.3.2. Contact lenses
7.2. Asia Pacific Ophthalmic Devices Market Outlook, By End User, Value (US$ Bn), 2018 – 2031
7.2.1. Key Highlights
7.2.1.1. Hospitals
7.2.1.2. Ambulatory Surgical Centers
7.2.1.3. Ophthalmic Clinics
7.2.1.4. Others
7.3. Asia Pacific Ophthalmic Devices Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
7.3.1. Key Highlights
7.3.1.1. China Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
7.3.1.2. China Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
7.3.1.3. Japan Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
7.3.1.4. Japan Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
7.3.1.5. South Korea Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
7.3.1.6. South Korea Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
7.3.1.7. India Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
7.3.1.8. India Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
7.3.1.9. Southeast Asia Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
7.3.1.10. Southeast Asia Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
7.3.1.11. Rest of Asia Pacific Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
7.3.1.12. Rest of Asia Pacific Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Latin America Ophthalmic Devices Market Outlook, 2018 – 2031
8.1. Latin America Ophthalmic Devices Market Outlook, By Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1. Diagnostic Devices
8.1.1.1.1. Optical Coherence Tomography (OCT) Scanners
8.1.1.1.2. SLIT Lamps
8.1.1.1.3. Ophthalmoscopes
8.1.1.1.4. Keratometers
8.1.1.1.5. Autorefractors
8.1.1.1.6. Ophthalmic Ultrasound Imaging Systems
8.1.1.1.7. Pachymeter
8.1.1.1.8. Others
8.1.1.2. Surgical Devices
8.1.1.2.1. Cataract Surgical Devices
8.1.1.2.2. Refractive Error Surgical Devices
8.1.1.2.3. Glaucoma Surgical Devices
8.1.1.2.4. Vitreoretinal Surgical Devices
8.1.1.3. Vision Care Devices
8.1.1.3.1. Spectacle Lenses
8.1.1.3.2. Contact lenses
8.2. Latin America Ophthalmic Devices Market Outlook, By End User, Value (US$ Bn), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Ambulatory Surgical Centers
8.2.1.3. Ophthalmic Clinics
8.2.1.4. Others
8.3. Latin America Ophthalmic Devices Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. Brazil Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
8.3.1.2. Brazil Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
8.3.1.3. Mexico Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
8.3.1.4. Mexico Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
8.3.1.5. Argentina Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
8.3.1.6. Argentina Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
8.3.1.7. Rest of Latin America Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
8.3.1.8. Rest of Latin America Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Middle East & Africa Ophthalmic Devices Market Outlook, 2018 – 2031
9.1. Middle East & Africa Ophthalmic Devices Market Outlook, By Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
9.1.1. Key Highlights
9.1.1.1. Diagnostic Devices
9.1.1.1.1. Optical Coherence Tomography (OCT) Scanners
9.1.1.1.2. SLIT Lamps
9.1.1.1.3. Ophthalmoscopes
9.1.1.1.4. Keratometers
9.1.1.1.5. Autorefractors
9.1.1.1.6. Ophthalmic Ultrasound Imaging Systems
9.1.1.1.7. Pachymeter
9.1.1.1.8. Others
9.1.1.2. Surgical Devices
9.1.1.2.1. Cataract Surgical Devices
9.1.1.2.2. Refractive Error Surgical Devices
9.1.1.2.3. Glaucoma Surgical Devices
9.1.1.2.4. Vitreoretinal Surgical Devices
9.1.1.3. Vision Care Devices
9.1.1.3.1. Spectacle Lenses
9.1.1.3.2. Contact lenses
9.2. Middle East & Africa Ophthalmic Devices Market Outlook, By End User, Value (US$ Bn), 2018 – 2031
9.2.1. Key Highlights
9.2.1.1. Hospitals
9.2.1.2. Ambulatory Surgical Centers
9.2.1.3. Ophthalmic Clinics
9.2.1.4. Others
9.3. Middle East & Africa Ophthalmic Devices Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
9.3.1. Key Highlights
9.3.1.1. GCC Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
9.3.1.2. GCC Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
9.3.1.3. South Africa Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
9.3.1.4. South Africa Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
9.3.1.5. Egypt Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
9.3.1.6. Egypt Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
9.3.1.7. Nigeria Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
9.3.1.8. Nigeria Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
9.3.1.9. Rest of Middle East & Africa Ophthalmic Devices Market By Product, Value (US$ Bn), 2018 – 2031
9.3.1.10. Rest of Middle East & Africa Ophthalmic Devices Market By End User, Value (US$ Bn), 2018 – 2031
9.3.2. BPS Analysis/Market Attractiveness Analysis
10. Competitive Landscape
10.1. Company Market Share Analysis, 2023
10.2. Competitive Dashboard
10.3. Company Profiles
10.3.1. Bausch & Lomb Incorporated
10.3.1.1. Company Overview
10.3.1.2. Product Portfolio
10.3.1.3. Financial Overview
10.3.1.4. Business Strategies and Development
10.3.2. Abbott
10.3.2.1. Company Overview
10.3.2.2. Product Portfolio
10.3.2.3. Financial Overview
10.3.2.4. Business Strategies and Development
10.3.3. Essilor International
10.3.3.1. Company Overview
10.3.3.2. Product Portfolio
10.3.3.3. Financial Overview
10.3.3.4. Business Strategies and Development
10.3.4. Carl Zeiss AG
10.3.4.1. Company Overview
10.3.4.2. Product Portfolio
10.3.4.3. Financial Overview
10.3.4.4. Business Strategies and Development
10.3.5. Canon, Inc.
10.3.5.1. Company Overview
10.3.5.2. Product Portfolio
10.3.5.3. Financial Overview
10.3.5.4. Business Strategies and Development
10.3.6. Alcon, Inc.
10.3.6.1. Company Overview
10.3.6.2. Product Portfolio
10.3.6.3. Financial Overview
10.3.6.4. Business Strategies and Development
10.3.7. Topson, Corp
10.3.7.1. Company Overview
10.3.7.2. Product Portfolio
10.3.7.3. Financial Overview
10.3.7.4. Business Strategies and Development
10.3.8. CooperVision AG
10.3.8.1. Company Overview
10.3.8.2. Product Portfolio
10.3.8.3. Financial Overview
10.3.8.4. Business Strategies and Development
10.3.9. Johnson and Johnson
10.3.9.1. Company Overview
10.3.9.2. Product Portfolio
10.3.9.3. Financial Overview
10.3.9.4. Business Strategies and Development
10.3.10. Hoya Corporation
10.3.10.1. Company Overview
10.3.10.2. Product Portfolio
10.3.10.3. Financial Overview
10.3.10.4. Business Strategies and Development
10.3.11. Nidek Co. Ltd.
10.3.11.1. Company Overview
10.3.11.2. Product Portfolio
10.3.11.3. Financial Overview
10.3.11.4. Business Strategies and Development
10.3.12. VisionCare, Inc.
10.3.12.1. Company Overview
10.3.12.2. Product Portfolio
10.3.12.3. Financial Overview
10.3.12.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations